FindTrial
Sign In

The efficacy of pulsed electromagnetic fields therapy in decreasing adverse events after fractional carbon dioxide laser

The efficacy of pulsed electromagnetic fields therapy in decreasing adverse events after fractional carbon dioxide laser for facial skin resurfacing: a double-blinded, randomized, sham-controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20221126001
Enrollment
36
Registered
2022-11-26
Start date
2023-03-14
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acne scar enlarge pores fine wrinkles pulsed electromagnetic fields therapy resurfacing laser fractional carbon dioxide laser downtime burning

Interventions

Fractional carbon dioxide laser (eCO2TM), tip 120 microns, 150 spots/cm2, pulse energy 50 mJ, power 30W Pulsed electromagnetic fields (ONDAMED GmbH, Kurzeller Str., Schwanau, Germany) program 52, 57 w
Active Comparator Device,Sham Comparator Device
fractional carbon dioxide laser and PEMF,fractional carbon dioxide laser and sham

Sponsors

Division of Dermatology, Department of Internal Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. acne scars 2. dilated pores 3. wrinkles

Exclusion criteria

Exclusion criteria: 1. active skin disease or infection on treatment site 2. history of keloid or hypertrophic scar 3. serious underlying medical conditions or history of immunocompromised, connective tissue disease, photosensitivity, skin cancer, Herpes simplex infection 4. history of previously taking oral vitamin A derivatives within 3 months, facial laser treatment or chemical peeling within 1 month 5. allergy to topical anesthesia 6. pregnancy or lactation 7. withdraw from the study

Design outcomes

Primary

MeasureTime frame
pain and burning sensation immediate after PEMF/sham, day 1-7 after treatment visual analogue scale—

Secondary

MeasureTime frame
erythema, edema, scab, pigment, hydration before and immediate after PEMF/sham, day1-28 after treatment erythema index, melanin index, presence of edema/scab, transepidermal water loss, skin hydration—

Countries

Thailand

Contacts

Public ContactPenpun Wattanakrai

Faculty of Medicine Ramathibodi Hospital, Mahidol University

maypenpun@gmail.com0818181103

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026